Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

21.20

+8.42 (65.88%)

At close: Mar 6, 2026, 4:00 PM EST

21.16

-0.04 (-0.19%)

After-hours: Mar 6, 2026, 7:58 PM EST

DAWN Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	158.18	131.16	-	-	-
Revenue Growth (YoY)	20.60%	-	-	-	-
Cost of Revenue	17.21	5.28	-	-	-
Gross Profit	140.97	125.88	-	-	-
Selling, General & Admin	120.59	115.45	75.54	61.29	29.16
Research & Development	148.14	227.7	130.52	85.62	43.58
Total Operating Expenses	268.72	343.15	206.06	146.91	72.74
Operating Income	-127.75	-217.27	-206.06	-146.91	-72.74
Interest Income	18.47	19.7	17.19	4.75	0
Other Non-Operating Income (Expense)	-0.02	109.22	-0.04	-0.02	-0.02
Total Non-Operating Income (Expense)	18.45	128.92	17.15	4.73	-0.01
Pretax Income	-109.3	-88.35	-188.92	-142.18	-72.75
Provision for Income Taxes	1.98	-7.14	-	-	-
Net Income	-107.32	-95.5	-188.92	-142.18	-170.64
Minority Interest in Earnings	-	-	-	-	-2.11
Net Income Attributable to Preferred Dividends	-	-	-	-	99.99
Net Income to Common	-107.32	-95.5	-188.92	-142.18	-170.64
Shares Outstanding (Basic)	103	93	80	65	37
Shares Outstanding (Diluted)	103	93	80	65	37
Shares Change (YoY)	10.70%	16.87%	21.85%	77.13%	568.42%
EPS (Basic)	-1.04	-1.02	-2.37	-2.17	-4.62
EPS (Diluted)	-1.04	-1.02	-2.37	-2.17	-4.62
Free Cash Flow	-104.08	-80.28	-147.08	-109.9	-48.54
Free Cash Flow Per Share	-1.01	-0.86	-1.84	-1.68	-1.31
Gross Margin	89.12%	95.98%	-	-	-
Operating Margin	-80.76%	-165.65%	-	-	-
Profit Margin	-67.85%	-72.81%	-	-	-
FCF Margin	-65.80%	-61.21%	-	-	-
EBITDA	-123.96	-215.24	-205.68	-146.38	-72.54
EBITDA Margin	-78.37%	-164.10%	-	-	-
EBIT	-127.75	-217.27	-206.06	-146.91	-72.74
EBIT Margin	-80.76%	-165.65%	-	-	-
Effective Tax Rate	-1.81%	8.09%	0.00%	0.00%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q